Risultati per: FDA approva una pillola contro la depressione a effetto rapido

Gli esperti, ‘anche i medici responsabili, colmare il divario’

The US Food and Drug Administration (FDA) recently approved liraglutide to treat type 2 diabetes in combination with diet and exercise, which makes it the first generic version of Victoza and the second glucagon-like peptide-1 (GLP-1) receptor agonist authorized as a generic drug.

New England Journal of Medicine, Ahead of Print.

Grocery items marketed as “healthy” will soon need to meet a new US Food and Drug Administration (FDA) rule that now focuses on whole foods.

The US Food and Drug Administration (FDA) recently approved tirzepatide, marketed as Zepbound, for moderate to severe obstructive sleep apnea (OSA) in adults with obesity, making it the first sleep apnea drug, according to an agency press release.

Al via la piattaforma online di psiconcologia ‘In buona salute’

Al via la piattaforma online di psiconcologia ‘In buona salute’

This study examines temporal trends in US Food and Drug Administration clearance summaries for pulse oximeters that report information about race and ethnicity and/or skin color or tone.

Il 30% più veloci per chi ne soffre

Cirio e Riboldi: ‘Altro fondamentale passo avanti’

Via a 2 fase del progetto Oms Europa coordinato in Italia da Iss

This JAMA Viewpoint investigates the rising popularity of nicotine pouches, especially among youths, and how the US Food and Drug Administration must act quickly to regulate these products and curb market growth.

Si è riunito il 29 gennaio per la prima seduta del 2025

This Viewpoint discusses California’s new law that will further strengthen tobacco control and whether the FDA and other states will follow California’s example.

New England Journal of Medicine, Ahead of Print.

Farmaco regolatore orexina ruolo chiave anche in psicopatologia